End of an Era: Emma Walmsley’s Transformative, Yet Divisive, Legacy at GSK
The surprise announcement that Dame Emma Walmsley will step down as CEO of GSK (GlaxoSmithKline) at the end of 2025 marks the conclusion of one […]
The surprise announcement that Dame Emma Walmsley will step down as CEO of GSK (GlaxoSmithKline) at the end of 2025 marks the conclusion of one […]